FDA Inspection 573369 — Bayer AG
The FDA completed an inspection of Bayer AG on March 10, 2009 in Bergkamen. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- March 10, 2009
- Fiscal Year
- 2009
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Bergkamen (Germany)